Jianzhao Zhai

Guoxue Alley No.37
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

PHLDB1 and WDFY4 as dual-state biomarkers in SLE pathogenesis and lupus nephritis prediction.

PHLDB1 and WDFY4 as dual-state biomarkers in SLE pathogenesis and lupus nephritis prediction.

Journal: BMC immunology

Published: September 08, 2025

Transcriptomic Determinants of Circulating Immunity Predict Immune-Related Adverse Events (irAEs) in Cancer Patients Receiving PD-1/PD-L1 Blockade.

Transcriptomic Determinants of Circulating Immunity Predict Immune-Related Adverse Events (irAEs) in Cancer Patients Receiving PD-1/PD-L1 Blockade.

Journal: Thoracic cancer

Published: June 13, 2025

Peripheral T-cell subset activation in NMDAR encephalitis: Insights into pathogenesis and biomarker potential for disease monitoring.

Peripheral T-cell subset activation in NMDAR encephalitis: Insights into pathogenesis and biomarker potential for disease monitoring.

Journal: Clinical immunology (Orlando, Fla.)

Published: March 02, 2025

Post-kidney transplantation EBV-related brainstem encephalitis.

Post-kidney transplantation EBV-related brainstem encephalitis.

Journal: QJM : monthly journal of the Association of Physicians

Published: December 27, 2024

KLHL11-associated rhomboencephalitis presenting as clippers-like syndrome.

KLHL11-associated rhomboencephalitis presenting as clippers-like syndrome.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: July 29, 2024

Circulating immunological transcriptomic profile identifies DDX3Y and USP9Y on the Y chromosome as promising biomarkers for predicting response to programmed death 1/programmed death ligand 1 blockade.

Circulating immunological transcriptomic profile identifies DDX3Y and USP9Y on the Y chromosome as promising biomarkers for predicting response to programmed death 1/programmed death ligand 1 blockade.

Journal: Chinese medical journal

Published: May 15, 2024

WNT16 as a promising biomarker for systemic lupus erythematosus and its role in regulating cell proliferation and apoptosis.

WNT16 as a promising biomarker for systemic lupus erythematosus and its role in regulating cell proliferation and apoptosis.

Journal: Clinical and experimental rheumatology

Published: December 18, 2023

Immunogenetic polymorphisms predict therapeutic efficacy and survival outcomes in tumor patients receiving PD-1/PD-L1 blockade.

Immunogenetic polymorphisms predict therapeutic efficacy and survival outcomes in tumor patients receiving PD-1/PD-L1 blockade.

Journal: International immunopharmacology

Published: May 08, 2023

IKBKE and BANK1 Polymorphisms and Clinical Characteristics in Chinese Women with Systemic Lupus Erythematosus.

IKBKE and BANK1 Polymorphisms and Clinical Characteristics in Chinese Women with Systemic Lupus Erythematosus.

Journal: Immunological investigations

Published: August 05, 2022

Allele frequency and proportion defined by circulating tumor DNA profiling predict tyrosine kinase inhibitors' therapeutic outcomes for non-small cell lung cancer.

Allele frequency and proportion defined by circulating tumor DNA profiling predict tyrosine kinase inhibitors' therapeutic outcomes for non-small cell lung cancer.

Journal: Journal of cancer research and clinical oncology

Published: January 03, 2022

Anti-Golgi Antibody as a Potential Indicator for Rheumatoid Arthritis.

Anti-Golgi Antibody as a Potential Indicator for Rheumatoid Arthritis.

Journal: Laboratory medicine

Published: August 20, 2021

Analysis of WDFY4 rs7097397 and PHLDB1 rs7389 polymorphisms in Chinese patients with systemic lupus erythematosus.

Analysis of WDFY4 rs7097397 and PHLDB1 rs7389 polymorphisms in Chinese patients with systemic lupus erythematosus.

Journal: Clinical rheumatology

Published: August 10, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026